FDA-Inspected Site

Paul W. Wallace, MD

3 FDA inspections are on record for Paul W. Wallace, MD in Los Angeles, United States.

483· Form 483 issued

Los Angeles, United States · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2026-03-17.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
9 Mar 2026 – 17 Mar 2026Human Drugs483View 483 →
12 Jun 2023 – 16 Jun 2023Human DrugsClean
4 Jun 2018 – 8 Jun 2018Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

17 Mar 2026
21 CFR 312.60

FD-1572, protocol compliance

Cited by Jasmine Y Wang, Bruno Baltazar

8 Jun 2018
21 CFR 312.60

FD-1572, protocol compliance

Cited by Theressa B Smith

8 Jun 2018
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Theressa B Smith

8 Jun 2018
21 CFR 312.62(c)

Record retention

Cited by Theressa B Smith

Investigators

FDA investigators tied to this site in the record.

Bruno Baltazar1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations2x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x
21 CFR 312.62(c)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Paul W. Wallace, MD's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat